Darolutamide and health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: An analysis of the phase III ARAMIS trial

Matthew R. Smith,Neal Shore,Teuvo L. Tammela,Albertas Ulys,Egils Vjaters,Sergey Polyakov,Mindaugas Jievaltas,Murilo Luz,Boris Alekseev,Iris Kuss,Marie-Aude Le Berre,Ateesha F. Mohamed,Dawn Odom,Jennifer Bartsch,Amir Snapir,Toni Sarapohja,Karim Fizazi

European Journal of Cancer（2021）

引用 25|浏览29

暂无评分

关键词

Darolutamide,Non-metastatic castration-resistant prostate cancer (nmCRPC),Quality of life,Urinary symptoms,Bowel symptoms,Hormonal treatment-related symptoms

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要